Ta strona została przetłumaczona automatycznie i dokładność tłumaczenia nie jest gwarantowana. Proszę odnieść się do angielska wersja za tekst źródłowy.

Teens Taking Charge: Managing Cancer Online

7 października 2019 zaktualizowane przez: Jennifer Stinson, The Hospital for Sick Children

Teens Taking Charge: A Pilot Randomized Controlled Trial of an Online Self-Management and Transitional Care Program for Youth With Cancer

Cancer is the most common potentially fatal disease of adolescence and the Internet represents an ideal means to deliver education, self-monitoring capabilities, and social support to enhance disease self-management by adolescents with cancer. While two interactive coping websites exist for young people with cancer, they are: (1) not interactive, (2) do not focus on helping youth gain skills for transition and independence, and (3) do not provide opportunities for meaningful social support. In summary, there is a crucial need to develop a comprehensive interactive Internet-based self-management program targeting AWC that is comprised of cancer education, self-management skills, and opportunities for social support, and that is cost-effective.

Przegląd badań

Szczegółowy opis

Overall aim of this program of research is to develop and evaluate the "Teens Taking Charge: Managing Cancer Online" Internet intervention that will help AWC to better cope with their disease, improve their HRQL, and enhance readiness to transition to adult health care using a sequential phased approach. The first phase of this project has determined the self-management and transitional care needs of adolescents with cancer. The second phase consisted of website development and usability testing to ensure the website is easy to use and understand, and is efficient and satisfying to complete. Subsequently, we will assess the feasibility of the program and the outcomes from the use of the site in a randomized controlled trial (RCT) pilot study (Phase 3). This will inform the design and methods of the main trial, and will permit us to obtain estimates of treatment effects on AWC health outcomes to inform the calculation of an appropriate sample size for the future definitive RCT (Phase 4). The focus of this study is Phase 3. Phase 4 will be a multicentre randomized controlled trial to assess outcomes for teens that complete the intervention as compared to those of an attention control group.

Typ studiów

Interwencyjne

Zapisy (Rzeczywisty)

73

Faza

  • Nie dotyczy

Kontakty i lokalizacje

Ta sekcja zawiera dane kontaktowe osób prowadzących badanie oraz informacje o tym, gdzie badanie jest przeprowadzane.

Lokalizacje studiów

    • Ontario
      • Hamilton, Ontario, Kanada, L8S 4K1
        • McMaster Children's Hospital
      • Ottawa, Ontario, Kanada, K1H 8L1
        • Children's Hospital Eastern Ontario
    • Quebec
      • Montreal, Quebec, Kanada, H3T 1C5
        • CHU Sainte-Justine

Kryteria uczestnictwa

Badacze szukają osób, które pasują do określonego opisu, zwanego kryteriami kwalifikacyjnymi. Niektóre przykłady tych kryteriów to ogólny stan zdrowia danej osoby lub wcześniejsze leczenie.

Kryteria kwalifikacji

Wiek uprawniający do nauki

12 lat do 18 lat (Dziecko, Dorosły)

Akceptuje zdrowych ochotników

Nie

Płeć kwalifikująca się do nauki

Wszystko

Opis

Inclusion Criteria:

  • Parents and adolescents will be eligible to participate if the adolescents are:

    1. between 12-18 years of age
    2. diagnosed with cancer (at least 3 months from diagnosis)
    3. on active treatment
    4. able to speak and read English and/or French at a Grade 6 level

Exclusion Criteria:

  • Adolescents will be excluded if they:

    1. have major cognitive impairments
    2. have reduced executive function that may impact their ability to understand and use the online program
    3. are terminal/palliative as determined by their oncologist Parents/caregivers are not eligible to participate in the study alone (without an adolescent)

Plan studiów

Ta sekcja zawiera szczegółowe informacje na temat planu badania, w tym sposób zaprojektowania badania i jego pomiary.

Jak projektuje się badanie?

Szczegóły projektu

  • Główny cel: Badania usług zdrowotnych
  • Przydział: Randomizowane
  • Model interwencyjny: Przydział równoległy
  • Maskowanie: Pojedynczy

Broń i interwencje

Grupa uczestników / Arm
Interwencja / Leczenie
Aktywny komparator: Grupa kontrolna
The control group is designed to control for the potential effects on outcomes of time, attention and computer use during the intervention. In addition to standard medical care, adolescents in the attention control group will be provided with access to a self-guided patient education study website, which will have two components: basic patient educational materials about Cancer ("Cancer Resource Centre") and online assessments.
Eksperymentalny: Grupa Eksperymentalna Przejęcia Ładu
n addition to standard medical care, adolescents in the experimental group will receive the "Taking Charge: Managing Cancer Online" Internet self-management program. The intervention is a 12-module interactive multi-component treatment protocol that consists of Cancer-specific education, self-management strategies, and social support that is available in English and French.

Co mierzy badanie?

Podstawowe miary wyniku

Miara wyniku
Opis środka
Ramy czasowe
Participant Accrual and Dropout Rates
Ramy czasowe: 12 weeks
These rates will be centrally tracked by the Clinical Research Project Coordinator
12 weeks
Fidelity (Any issues or difficulties encountered during implementation of the intervention, control strategy, or outcome measures)
Ramy czasowe: 12 weeks
Any issues or difficulties encountered during implementation of the intervention, control strategy, or outcome measures will be tracked throughout the study by the Clinical Research Project Coordinator
12 weeks
Acceptability and Satisfaction with Intervention (rate their acceptability of and satisfaction with the intervention)
Ramy czasowe: 12 weeks
Post-treatment, adolescents with cancer and their parents in the intervention group will rate their acceptability of and satisfaction with the intervention
12 weeks
Engagement with Intervention (Google Analytics will be used to track patterns of website program usage)
Ramy czasowe: 12 weeks
Google Analytics will be used to track patterns of website program usage by adolescents with cancer and their parents
12 weeks

Miary wyników drugorzędnych

Miara wyniku
Opis środka
Ramy czasowe
Knowledge (Adolescent Cancer Knowledge Questionnaire)
Ramy czasowe: 12 weeks
Measured using the Adolescent Cancer Knowledge Questionnaire, a 15-item tool that assesses cancer-specific knowledge.
12 weeks
Self-Efficacy (Generalized Self-Efficacy-Sherer Scale)
Ramy czasowe: 12 weeks
Measured by the Generalized Self-Efficacy-Sherer Scale, a 12-item scale that requires adolescents to indicate their level of agreement with a series of statements about self-efficacy.
12 weeks
Treatment adherence (Medication Adherence Scale)
Ramy czasowe: 12 weeks
Measured with the Medication Adherence Scale, a 4-item scale for assessing self-reported adherence.
12 weeks
Physical Symptoms - Pain (short form Brief Pain Inventory (BPI)
Ramy czasowe: 12 weeks
Measured using the short form Brief Pain Inventory (BPI), a 15-item measure that includes scales for measuring pain intensity, impact of pain on functioning and well being, and pain interference.
12 weeks
Physical Symptoms - Fatigue (PedsQL Multidimensional Fatigue Module)
Ramy czasowe: 12 weeks
Measured using the PedsQL Multidimensional Fatigue Module, an 18-item scale with validated versions for child report (ages 8-12 years), teen report (ages 13-18 years), and parental report for children and teens.
12 weeks
Emotional symptoms (Hospital Anxiety and Depression Scale (HADS)
Ramy czasowe: 12 weeks
Measured using the Hospital Anxiety and Depression Scale (HADS), a 14-item measure for individuals aged >12 years, which can be completed within 2-5 minutes.
12 weeks
Social functioning (Perceived Social Support from Friends (PSS-Fr) Scale)
Ramy czasowe: 12 weeks
Measured with the Perceived Social Support from Friends (PSS-Fr) Scale, a 20-item scale that assesses the extent to which an individual perceives that their friends fulfill their needs for support.
12 weeks
Transition readiness (Cancer Transition Scales)
Ramy czasowe: 12 weeks
Measured with the Cancer Transition Scales, which include sub-scales for 'cancer worry' (6 items), 'self-management skills' (15 items), and 'expectations' (12 items).
12 weeks
Health Related Quality of Life (PedsQL Cancer Module)
Ramy czasowe: 12 weeks
measured with the PedsQL Cancer Module, a 27-item scale, which has validated versions for child, teen, and parental report, and the Health Utility Index [HUI].
12 weeks
Cost effectiveness (ascertaining direct health care costs and family out of pocket costs)
Ramy czasowe: 12 weeks
Measured by ascertaining direct health care costs and family out of pocket costs related to cancer care incurred over the 12-week study period using the Health Care Utilization form modified from the Ambulatory and Home Care Record84-90 as well as direct costs related to the online intervention technology, intervention training and personnel. Quality adjusted life years will be calculated using the HUI to determine the incremental cost-effectiveness
12 weeks

Współpracownicy i badacze

Tutaj znajdziesz osoby i organizacje zaangażowane w to badanie.

Daty zapisu na studia

Daty te śledzą postęp w przesyłaniu rekordów badań i podsumowań wyników do ClinicalTrials.gov. Zapisy badań i zgłoszone wyniki są przeglądane przez National Library of Medicine (NLM), aby upewnić się, że spełniają określone standardy kontroli jakości, zanim zostaną opublikowane na publicznej stronie internetowej.

Główne daty studiów

Rozpoczęcie studiów (Rzeczywisty)

1 stycznia 2016

Zakończenie podstawowe (Rzeczywisty)

1 kwietnia 2019

Ukończenie studiów (Rzeczywisty)

1 kwietnia 2019

Daty rejestracji na studia

Pierwszy przesłany

17 listopada 2014

Pierwszy przesłany, który spełnia kryteria kontroli jakości

21 listopada 2014

Pierwszy wysłany (Oszacować)

24 listopada 2014

Aktualizacje rekordów badań

Ostatnia wysłana aktualizacja (Rzeczywisty)

9 października 2019

Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości

7 października 2019

Ostatnia weryfikacja

1 października 2019

Więcej informacji

Terminy związane z tym badaniem

Inne numery identyfikacyjne badania

  • 1000045896

Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .

Subskrybuj